Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lina Yu

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Pain|March 27, 2024
Characterizing the opioidergic mechanisms of repetitive transcranial magnetic stimulation-induced analgesia: a randomized controlled trialYing Liu, Junfeng Sun, Chaomin Wu, et al.
Science Signaling|June 17, 2025
Amphiregulin contributes to neuropathic pain by enhancing glycolysis that stimulates histone lactylation in sensory neuronsYu-Tao Deng, Longfei Ma, Yixiao Mei, et al.
Journal of Leukocyte Biology|May 22, 2024
Elevations in presepsin, PCT, hs-CRP, and IL-6 levels predict mortality among septic patients in the ICUYan Zhou, Yongwen Feng, Xiaomin Liang, et al.
BMJ Global Health|December 11, 2023
Low scoring IHR core capacities in low-income and lower-middle-income countries, 2018-2020Barbara Burmen, Cynthia Bell, Guna Nidhi Sharma, et al.
Eclinicalmedicine|August 21, 2025
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studyLiying Zhao, Hao Liu, Jiang Yu, et al.
Nature Communications|April 23, 2026
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trialLiying Zhao, Hao Liu, Yanfeng Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2019
IgGs from patients with amyotrophic lateral sclerosis and diabetes target Ca<sub>V</sub>α<sub>2</sub>δ1 subunits impairing islet cell function and survivalYue Shi, Kyoung Sun Park, Seung Hyun Kim, et al.
The Journal of Experimental Medicine|November 11, 2021
ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neuronsLongfei Ma, Lina Yu, Bao-Chun Jiang, et al.
Nurse Education in Practice|June 14, 2017
Mentors' and mentees' intellectual-partnership through the lens of the Transformative Learning TheoryMargareth Santos Zanchetta, Annette Bailey, Olesya Kolisnyk, et al.
Nature Communications|November 28, 2025
ZFP612 controls neuropathic pain through epigenetic repression of Il1rl1 within the silencer-promoter loop in primary sensory neurons of male miceLongfei Ma, Yangyuxin Huang, Meiling Han, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Pain|March 27, 2024
Characterizing the opioidergic mechanisms of repetitive transcranial magnetic stimulation-induced analgesia: a randomized controlled trialYing Liu, Junfeng Sun, Chaomin Wu, et al.
Science Signaling|June 17, 2025
Amphiregulin contributes to neuropathic pain by enhancing glycolysis that stimulates histone lactylation in sensory neuronsYu-Tao Deng, Longfei Ma, Yixiao Mei, et al.
Journal of Leukocyte Biology|May 22, 2024
Elevations in presepsin, PCT, hs-CRP, and IL-6 levels predict mortality among septic patients in the ICUYan Zhou, Yongwen Feng, Xiaomin Liang, et al.
BMJ Global Health|December 11, 2023
Low scoring IHR core capacities in low-income and lower-middle-income countries, 2018-2020Barbara Burmen, Cynthia Bell, Guna Nidhi Sharma, et al.
Eclinicalmedicine|August 21, 2025
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studyLiying Zhao, Hao Liu, Jiang Yu, et al.
Nature Communications|April 23, 2026
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trialLiying Zhao, Hao Liu, Yanfeng Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2019
IgGs from patients with amyotrophic lateral sclerosis and diabetes target Ca<sub>V</sub>α<sub>2</sub>δ1 subunits impairing islet cell function and survivalYue Shi, Kyoung Sun Park, Seung Hyun Kim, et al.
The Journal of Experimental Medicine|November 11, 2021
ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neuronsLongfei Ma, Lina Yu, Bao-Chun Jiang, et al.
Nurse Education in Practice|June 14, 2017
Mentors' and mentees' intellectual-partnership through the lens of the Transformative Learning TheoryMargareth Santos Zanchetta, Annette Bailey, Olesya Kolisnyk, et al.
Nature Communications|November 28, 2025
ZFP612 controls neuropathic pain through epigenetic repression of Il1rl1 within the silencer-promoter loop in primary sensory neurons of male miceLongfei Ma, Yangyuxin Huang, Meiling Han, et al.
Pageof 26